Tandlæge Trane-Restrup ApS: Financial statements 2023
CVR: 39750333
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Tandlæge Trane-Restrup ApS (CVR 39750333) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -111,314 and a net result of DKK 70,378 compared with DKK 155,300 the year before. Equity in the 2023 report amounted to DKK 540,962. The solvency ratio was 43.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -111,314
- Profit/Loss
- DKK 70,378
- Equity
- DKK 540,962
- Total Assets
- DKK 1,244,226
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -111K | 70K | 541K | 1 |
| 2022 | - | -83K | 155K | 588K | 1 |
| 2021 | - | -86K | 191K | 547K | 1 |
| 2020 | - | -94K | 182K | 466K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Tandlæge Trane-Restrup ApS has published its annual report for 2022. Gross profit came to DKK -82,530, and the net result was DKK 155,300.
About Tandlæge Trane-Restrup ApS
Tandlæge Trane-Restrup ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2018. The company is registered under the industry Tandlægers aktiviteter. The management consists of Martine Majken Trane-Restrup. The company is owned by Martine Majken Trane-Restrup. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -98,052 and a net result of DKK 82,091 compared with DKK 170,441 the year before. Equity in the 2025 report amounted to DKK 645,940.
